Atlas Trials

Intermittent Androgen Deprivation Therapy in the Era of AR Pathway Inhibitors

Clinical trial NCT05974774 · RECRUITING

Trial details

NCT number
NCT05974774
Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2025-05-23
Primary completion
2035-05-23
Enrollment
1600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.